Recombinant Human Anti-OR14C36 Soluble TCR (MF8) (C-Cys) (CAT#: VS-0622-YF4780)
Human TCR (MF8) recognizes OR14C36 peptide (FMLYLLTLM) in the context of HLA-A2. Soluble TCR is expressed with C-terminal Cys strategy (TRAV-TRAC partial-Cys, TRBV-TRBC partial-Cys). Depending the C-terminal Cys, two chains form heterodimer. Please note that the activity is not guaranteed.
Specific Inquiry
Specifications
- Host Species
- Human
- Target
- OR14C36
- Epitope
- FMLYLLTLM
- MHC
- HLA-A2
- Clone
- MF8
- Type
- Soluble TCR (C-Cys)
- TCR Expression Strategy
- C-Cys strategy: the alpha and beta chain (without transmembrane and cytosolic region) can form heterodimer based on C-terminal Cys. The soluble TCR contains variable regions and partial constant regions.
Target
- Alternative Names
- Olfactory Receptor Family 14 Subfamily C Member 36 variant FML_V6L; FMLYLLTLM
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "Clone MF8"
Customer Reviews and Q&As
There are currently no Customer reviews or questions for VS-0622-YF4780. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: WB, FuncS, IF, Neut, ELISA, FC, IP
Application: FC, IP, ELISA, Neut, FuncS, IF, WB
Application: ELISA, FC, IP, FuncS, IF, Neut, ICC
Application: IP, IF, FuncS, FC, Neut, ELISA, ICC
Application: IHC, ELISA, FC, WB, ADCC, FuncS
Application: Neut, Inhib, FC, ELISA
Application: ELISA, IHC, FC, IP, IF, FuncS
Application: ELISA, Inhib, FuncS
Application: ELISA
Application: ELISA, Neut
Application: ELISA, Block, WB, FC, IP
For Research Use Only. Not For Clinical Use.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
